Details
Nebilong Indications
Essential hypertension.
Chronic heart failure - as a complement to standard therapies in elderly patients of 70 years.
Contradictions
Hypersensitivity to the active substance or any other drug. Liver failure or liver dysfunction. Acute heart failure, cardiogenic shock or episodes of heart failure decompensation requiring intravenous drug substances with a positive inotropic effect. Sick sinus syndrome, including sinuauricular block, atrioventricular block II-III (without artificial pacemaker). Bronchospasm and bronchial asthma in history. Untreated pheochromocytoma. Metabolic acidosis. Bradycardia (before treatment heart rate less than 60 beats per minute). Hypotension (systolic blood pressure less than 90 mm Hg.), Severe peripheral circulation.
Dosage & Administration
Essential hypertension. Adults take 1 tablet nebilonhu (5 mg nebivolol) a day, if possible at the same time. The drug can be taken while eating. Anti-hypertensive effect appears after 1-2 weeks of treatment, but sometimes the optimal effect is observed only after 4 weeks. Nebilonh can be used both alone and in combination with other antihypertensive agents. Until additional antihypertensive effect was observed only in combination with its 12.5 - 25 mg of hydrochlorothiazide.
Chronic heart failure. Treatment of chronic heart failure should begin with a slow dose titration to achieve optimal individual maintenance dose.
Such patients are prescribed with the drug if there is chronic heart failure without acute episodes of decompensation within the last 6 weeks.
